Assessment of Depression, Anxiety, and Quality of Life in Patients With Psoriasis Using the Dermatology Life Quality Index (DLQI) and Depression Anxiety Stress Scale-21 (DASS-21): A Cross-Sectional Study From Southern India
Cureus · 21.05.2026
DOI: 10.7759/cureus.109326 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Cureus, erschienen am 21.05.2026. Verfasst von Naveen Manohar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology, The Oxford Medical College, Hospital and Research Centre, Bengaluru, IND. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Depression
Abstract (Originalsprache)
Introduction
Psoriasis is a chronic inflammatory skin disorder associated with significant psychosocial morbidity. Despite its visible nature and impact on daily functioning, data from India on the prevalence of depression and anxiety in psoriasis patients remains limited. This study aimed to evaluate psychological morbidity and its relationship with disease severity and quality of life (QoL) in patients with psoriasis.
Methods
A cross-sectional study was conducted among 63 adult patients with psoriasis attending a tertiary care teaching hospital in Southern India between February 2021 and August 2022. Patients aged 18-65 years with disease duration ≥12 months and without major comorbidities were included. Disease severity was assessed using the Psoriasis Area Severity Index (PASI), QoL was assessed using the Dermatology Life Quality Index (DLQI), and psychological status was assessed using the Depression Anxiety Stress Scale (DASS-21). Statistical analyses included independent t-test, Mann-Whitney U test, chi-square test, and Spearman correlation, with p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology, The Oxford Medical College, Hospital and Research Centre, Bengaluru, IND.
- Dermatology, Belagavi Institute of Medical Sciences, Belagavi, IND.
- Dermatology, Indira Medical College and Hospitals, Pandur, IND.
Zitieren
APA
Manohar, N., Pise, G. A., Prasad, S. S., Dastikop, S. V., Hosthota, A., & Patil, M. N. (2026). Assessment of Depression, Anxiety, and Quality of Life in Patients With Psoriasis Using the Dermatology Life Quality Index (DLQI) and Depression Anxiety Stress Scale-21 (DASS-21): A Cross-Sectional Study From Southern India. Cureus. https://doi.org/10.7759/cureus.109326
Vancouver
Manohar N, Pise GA, Prasad SS, Dastikop SV, Hosthota A, Patil MN. Assessment of Depression, Anxiety, and Quality of Life in Patients With Psoriasis Using the Dermatology Life Quality Index (DLQI) and Depression Anxiety Stress Scale-21 (DASS-21): A Cross-Sectional Study From Southern India. Cureus. 2026. doi:10.7759/cureus.109326
BibTeX
@article{Manohar2026,
author = {Manohar, Naveen and Pise, Gajanan A and Prasad, Shruthi S and Dastikop, Shilpa V and Hosthota, Abhineetha and Patil, Malteshgouda N},
title = {Assessment of Depression, Anxiety, and Quality of Life in Patients With Psoriasis Using the Dermatology Life Quality Index (DLQI) and Depression Anxiety Stress Scale-21 (DASS-21): A Cross-Sectional Study From Southern India},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.109326}
}
EUVIMED